| View |
|
DRP-8745-06
|
Cefuroxime (as sodium)
|
Zefuped
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
29 February 2024
|
20 February 2025
|
| View |
|
DRP-8811-03
|
dl-Alpha Tocopherol Acetate (Vitamin E)
|
Beauty-E
|
400 IU
|
Softgel Capsule
|
Vitamins
|
Kanion Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
01 March 2024
|
13 April 2025
|
| View |
|
DRP-8994-12
|
Gliclazide
|
None
|
60 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
01 March 2024
|
14 August 2025
|
| View |
|
DRP-906-07
|
Losartan Potassium
|
Jisartan
|
50 mg
|
Film-Coated Tablet
|
Angiotensin-2-Receptor Blocker (ARBs)
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
01 March 2024
|
22 April 2028
|
| View |
|
DRP-9075-01
|
Citicoline (as sodium)
|
Citiquest
|
500 mg
|
Film-Coated Tablet
|
Psychostimulant/Nootropic
|
Healer's Lab (Unit II)
|
India
|
CLIDP Conversion
|
27 February 2024
|
06 May 2026
|
| View |
|
DRP-9166-08
|
Clopidogrel (as bisulfate)
|
Cardiplat
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
03 March 2024
|
21 September 2025
|
| View |
|
DRP-9195-12
|
Ascorbic Acid + Zinc
|
Curecee Plus
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate)/10 mg
|
|
Vitamin/Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
18 February 2024
|
02 October 2028
|
| View |
|
DRP-9197-01
|
Paracetamol
|
Aeknel
|
150 mg/ mL
|
Solution for Injection (IM/IV)
|
Analgesic/ Antipyretic
|
Akums Drugs & Pharmaceuticals Ltd. (Plant III - Injectables)
|
India
|
CLIDP Conversion
|
19 February 2024
|
15 February 2026
|
| View |
|
DRP-9415-03
|
Iohexol
|
Prohexon 350
|
755 mg/mL (eq. to 350 mg/mL Iodine)
|
Solution for Injection
|
X-ray Contrast media, Iodinated (Watersoluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
23 December 2025
|
| View |
|
DRP-9391-07
|
Telmisartan
|
Telimac 80
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics Private Limited
|
India
|
CLIDP Conversion
|
18 February 2024
|
02 March 2026
|
| View |
|
DRP-9390-10
|
Telmisartan
|
Telimac 40
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics & Chemicals Ltd.
|
India
|
CLIDP Conversion
|
21 February 2024
|
02 March 2026
|
| View |
|
DRP-9390-09
|
Telmisartan
|
Medisartan
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics Private Limited
|
India
|
CLIDP Conversion
|
19 January 2024
|
02 March 2026
|
| View |
|
DRP-9330-01
|
Paracetamol + Ascorbic Acid
|
Tempra Boost-C
|
500 mg/40 mg
|
Granules for Solution
|
Analgesic/Antipyretic/Vitamin
|
Interphil Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
26 February 2024
|
30 June 2025
|
| View |
|
DRP-9416-03
|
Iohexol
|
Hextar
|
647 mg/mL (eq. to 300mg/mL Iodine)
|
Solution for Injection
|
X-Ray Contrast Media, Iodinated (Water soluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 February 2024
|
23 December 2025
|
| View |
|
DRP-9668-02
|
Ceftriaxone (as sodium)
|
Gotrax
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
19 February 2024
|
27 April 2026
|
| View |
|
DRP-9688-01
|
Levocetirizine Dihydrochloride
|
Histaquest
|
5 mg
|
Film-Coated Tablet
|
Antihistamine
|
Healer's Lab (Unit II)
|
India
|
CLIDP Conversion
|
27 February 2024
|
18 May 2026
|
| View |
|
DRP-9879-02
|
Carvedilol
|
Unbranded
|
6.25 mg
|
Film-Coated Tablet
|
Beta-Adrenoceptor Blocker
|
Medley Pharmaceuticals Limited
|
India
|
Renewal
|
02 August 2024
|
25 February 2030
|
| View |
|
DRP-9975-11
|
Cefuroxime (as axetil)
|
Cefupen -5 00
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
19 January 2024
|
01 July 2026
|
| View |
|
DRP-9984-04
|
Telmisartan + Hydrochlorothiazide
|
Telzyd H 80/12.5
|
80mg/12.5mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Diuretic
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
06 February 2024
|
14 June 2029
|
| View |
|
HRP-183-01
|
Ascorbic Acid + Zinc
|
Curecee Plus
|
100 mg/ 10 mg per mL
|
Syrup
|
Vitamin/Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
18 February 2024
|
24 January 2028
|